login
  Password reminder
NeuroNews
Contact the editor Visit NeuroNews Twitter feed Visit NeuroNews Facebook page
 

Preliminary results with the Web aneurysm device for bifurcation aneurysms


Monday, 23 Jul 2012 17:32
Web device
Web device


Preliminary data regarding the use of the Web Aneurysm Embolization System (Sequent Medical) were shared at LINNC 2012 in Paris, France, and published in a recent study in the American Journal of Neuroradiology.  The early evidence suggests that this device represents a feasible and promising treatment for wide-neck bifurcation aneurysms, and that further study and clinical experience is warranted.


Web, according to the company, is designed to bridge the aneurysm neck and promote rapid, periprocedural stasis in both ruptured and unruptured aneurysms via an intrasaccular approach.

Laurent Pierot, Maison Blanche Hospital, Reims, France, presented on the use of both computational flow dynamics and preclinical models in the development of the Web device. He also reported on his own clinical experience. Initial results from the treatment of twenty-one aneurysms with the Web in France and Germany were recently published in the American Journal of Neuroradiology and found that intrasaccular flow disruption was a feasible treatment, particularly in bifurcation aneurysms with unfavourable anatomy. The authors of the study noted that further studies were needed to evaluate the indications, safety, and efficacy of this new technique.


Pierot made the point that the endovascular treatment of large aneurysms with wide-necks is often challenging and associated with a high incidence of significant recurrences. “The Web, an intrasaccular flow disrupter, was designed for use in this type of aneurysm. We report our early experience with this device in this multicentre study,” he said.


Laurent Pierot
Laurent Pierot

Pierot and colleagues reported that 20 patients with 21 aneurysms were treated by using the Web in three European centres. The team made a note of successful deployment of the Web, immediate post-treatment angiographic results, adverse events, clinical outcome, and angiographic follow-up results.

 

The majority of aneurysms were located in the middle cerebral artery (8/21, 38.1%). Five were located on the anterior communicating artery (23.8%), and four (19.1%) each on the basilar artery and internal carotid artery.

 

The investigators did not report any treatment failures. Over 75% of patients were treated exclusively with the Web device. The other patients required additional coiling and/or stent placement. The team noted that one patient (4.8%) experienced transient clinical worsening (mRS 1 at one month and mRS 0 at three months) related to a thromboembolic event.  They noted a detachment of the Web device which was subsequently retrieved without adverse effects.

 

Pierot told LINNC delegates that short-term follow-up (2–8 months) had revealed total occlusion or neck remnant in 80% of aneurysms.

 

At LINNC 2012, Boris Lubicz, Hôpital Erasme, Brussels, Belgium also presented his as-yet unpublished initial clinical experience with the Web for treatment of twenty-one wide neck unruptured bifurcation aneurysms, which represents that largest single centre experience to date.

 

Sequent Medical told NeuroNews that the company intends to continue with a controlled, gradual introduction of the Web at centres in Europe. The company is also initiating a number of Europe-based clinical studies in order to collect formal multicentre clinical data.

 



Add New Comment

Most popular


Next generation Medina coil system shows improvements in early human experience
Thursday, 26 Feb 2015
In early use of the Medina coil system, researchers have found the device to be a next generation coil that combines the familiar procedural safety and technique associated with conventional coils, ... Next generation Medina coil system shows improvements in early human experience

Better outcomes observed in MR CLEAN non-general anaesthesia subgroup in post-hoc analysis
Thursday, 02 Apr 2015
In a post-hoc analysis of the use of general anaesthesia in the MR CLEAN trial (Multicenter randomized clinical trial of endovascular treatment for acute ischemic stroke in the Netherlands) ... Better outcomes observed in MR CLEAN non-general anaesthesia subgroup in post-hoc analysis

Cover device proves more effective than guide catheter in stroke model
Wednesday, 18 Mar 2015
In an in vitro stroke model comparison, the use of the Cover accessory device (Lazarus Effect) in conjunction with a stent retriever resulted in higher successful recanalisation rates, no embolic ... Cover device proves more effective than guide catheter in stroke model

Features


New day in acute ischaemic stroke therapy
Friday, 17 Apr 2015
The newest generation of trials for acute ischaemic stroke, including MR CLEAN, ESCAPE, EXTEND IA and SWIFT PRIME, appear to have ushered in a new era in stroke therapy. Now, Joseph Broderick (... New day in acute ischaemic stroke therapy

Flow diverter technology for intracranial aneurysms
Tuesday, 31 Mar 2015
Gabor Toth writes for NeuroNews about the flow diverters that are currently available and the ongoing clinical trials that could have the potential to extend the indications of flow diverter therapy ... Flow diverter technology for intracranial aneurysms

Profiles


Joseph Broderick
Wednesday, 07 Jan 2015
Joseph Broderick speaks to NeuroNews about the future of neurology and his research, in particular, ... Joseph Broderick

Vladimír Beneš Jr
Tuesday, 30 Sep 2014
Vladimír Beneš Jr is professor and chair at the First Medical School, Charles University, P... Vladimír Beneš Jr

Cardiac Rhythm News Vascular News Cardiovascular News Interventional News Spinal News NeuroNews
BIBA Medical BIBA MedTech Insights CX Symposium ilegx
 
Password Reminder

BIBA Medical, 526 Fulham Road, Fulham, London, SW6 5NR.
TEL: +44 (0)20 7736 8788 FAX: +44 (0)20 7736 8283 EMAIL: 
info@bibamedical.com
© BIBA Medical Ltd is a company registered in England and Wales with company number 2944429.
VAT registration number 730 6811 50.
Site Map | Terms and Conditions